by last | Jul 6, 2022 | 2022, Past Events
Dr. Ettore Gilardoni, Head of Bio-MS at Philogen, will present a poster entitled: A mass spectrometry-based method for the determination of in vivo biodistribution of small molecule-metal conjugates. Dr. Gilardoni will also give a presentation on August 31st,...by last | Jun 27, 2022 | 2022, Past Events
Philogen will be Bronze Sponsor of the Post-Chicago Meeting in Münich (30-1 July). Philogen will chair a Satellite Symposium on Friday July 1, 11.30-12.00 am. Dr. Alfredo Covelli, Philogen’s CMO, will give a presentation entitled “Immunocytokines for the therapy...by Lisa Nadal | Jun 27, 2022 | 2022, Past Events, Scientific
Philogen will attend the 3rd Annual Cytokine-Based Drug Development Summit in Boston. Roberto De Luca, Head of Antibody Therapeutics, will give a virtual lecture entitled “Antibody-cytokine fusion proteins against Fibroblast Activation Protein (FAP)” on the 28...by last | Jun 27, 2022 | 2022, Past Events
Philogen will attend the 13th World ADC in San Diego (USA) in September 2022. Samuele Cazzamalli, Head of Small Molecules Therapeutics at Philogen, will give a lecture in person entitled “Pan-Tumoral Small Molecule-Drug Conjugates Targeting Fibroblasts Activation...by last | Jun 27, 2022 | 2022, Past Events
Philogen attends ESMO in September 2022. Tobias Weiss, MD/PhD, Neuro-Oncologist at the Universitätsspital Zürich, to give a presentation entitled “The combination of lomustine and antibody-based targeted TNF (L19TNF) as a promising treatment for recurrent...by last | Jun 27, 2022 | 2022, Past Events
Philogen will attend EANO Meeting in Vienna in September 2022. More details on the lecture held by Philogen will follow shortly. Please visit the EANO Meeting Website for additional information.